However, in the context of cancer, IL-33 aids in tumor immune evasion by upregulating the activity, survival and expansion of myeloid derived suppressor cells via ST2 signaling, which was reduced in ST2−/− mice (Xiao et al., 2016). Here, IL33 is linked to cancer.